| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8232887 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 11 Pages |
Abstract
There is a statistically significant increased risk of various adverse gastrointestinal events with dose-escalated CFRT. This remains at clinically acceptable levels, and overall prevalence ultimately decreases with duration of follow-up.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Isabel F.R.C.R., Rachel C. M.Sc., Matthew R. C.Stat., John D. F.R.C.R., David P. F.R.C.R., MRC RT01 collaborators MRC RT01 collaborators,